Invention Grant
US09095564B2 von Willebrand factor or factor VIII and von Willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes
有权
血管性血友病因子或因子VIII和血管性血友病因子用于治疗由血小板抑制剂诱导的凝血病
- Patent Title: von Willebrand factor or factor VIII and von Willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes
- Patent Title (中): 血管性血友病因子或因子VIII和血管性血友病因子用于治疗由血小板抑制剂诱导的凝血病
-
Application No.: US14071193Application Date: 2013-11-04
-
Publication No.: US09095564B2Publication Date: 2015-08-04
- Inventor: Gerhard Dickneite , Ingo Pragst , Henrique Lessa , Thorsten Haas , Stefan Zeitler
- Applicant: CSL Behring GmbH
- Applicant Address: DE Marburg
- Assignee: CSL Behring GmbH
- Current Assignee: CSL Behring GmbH
- Current Assignee Address: DE Marburg
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Priority: DE102008032361 20080710
- Main IPC: A61K38/37
- IPC: A61K38/37 ; C07K14/755 ; A61K38/36
Abstract:
The present invention relates to a von Willebrand Factor for use in the treatment and/or prevention of a bleeding event associated with a thrombopathy induced by substances inhibiting thrombocytes. Furthermore, the present invention relates to a method of treating and/or preventing a disorder related to a bleeding event associated with a thrombopathy induced by substances inhibiting thrombocytes comprising administering a pharmaceutically effective amount of a von-Willebrand-Factor (vWF) to a patient in need thereof. The present invention also relates to a composition comprising vWF and a composition comprising FVIII for simultaneous, separate or sequential use for use in the treatment and/or prevention of a bleeding event associated with a thrombopathy induced by substances inhibiting thrombocytes.
Public/Granted literature
Information query
IPC分类:
